Arabic Arabic English English French French German German
dark

EH Nexus Webinar – October 14, 2021

Magellan Diagnostics, Inc. and the U.S. Food and Drug Administration (FDA) have issued a recall notice concerning the use of some LeadCare® Blood Lead Tests (certain LeadCare II, LeadCare Plus, and LeadCare Ultra test kit lots). The use of these devices may cause serious injuries because they might underestimate blood lead levels. The FDA has identified this as a Class I recall, the most serious type of recall.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

EH Nexus Webinar – October 27, 2021

Next Post

Researchers find new link between a disrupted body clock and inflammatory diseases

Related Posts
Total
0
Share